InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by MURPHY ANDREW J, Vice-Président Exécutif Recherche. Director active across 1 company, notably Regeneron Pharmaceuticals, INC.. In total, 8 filings have been recorded. Activity tracked since 16 August 2021. The latest transaction was disclosed on 16 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
10,000 shares@ US$179.130.0023% mcap41.7% of flowCommon StockSEC:0001883850-22-000046:0
10,000 shares@ US$179.130.0022% mcap38.3% of flowCommon StockSEC:0001708138-22-000014:0
697 shares@ US$664.340.0006% mcap10.0% of flowCommon StockSEC:0001708138-21-000105:0
697 shares@ US$664.340.0006% mcap100.0% of flowCommon StockSEC:0001708138-21-000105
3,462 shares0Common StockSEC:0001708138-21-000098:0
3,462 shares0Common StockSEC:0001708138-21-000098
1,645 shares0Common StockSEC:0001708138-21-000086:0
1,645 shares0Common StockSEC:0001708138-21-000086
8 of 8 declarations
About MURPHY ANDREW J
Andrew J. Murphy is Executive Vice President of Research at REGENERON PHARMACEUTICALS, INC. He is responsible for leading the company's research initiatives, contributing to innovation in the pharmaceutical sector.
